B. Riley Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-314
| Closed | -$213K | – | 1007 |
|
|
2025
Q4 | $213K | Buy |
+314
| New | +$214K | 0.01% | 844 |
|
|
2024
Q4 | $760K | Buy |
1,838
+905
| +97% | +$397K | 0.02% | 543 |
|
|
2024
Q3 | $466K | Sell |
933
-722
| -44% | -$351K | 0.01% | 767 |
|
|
2024
Q2 | $806K | Sell |
1,655
-224
| -12% | -$112K | 0.02% | 610 |
|
|
2024
Q1 | $822K | Buy |
1,879
+495
| +36% | +$271K | 0.02% | 593 |
|
|
2023
Q4 | $768K | Sell |
1,384
-495
| -26% | -$232K | 0.02% | 618 |
|
|
2023
Q3 | $822K | Buy |
1,879
+319
| +20% | +$159K | 0.02% | 593 |
|
|
2023
Q2 | $783K | Sell |
1,560
-67
| -4% | -$32.1K | 0.02% | 660 |
|
|
2023
Q1 | $814K | Buy |
1,627
+396
| +32% | +$190K | 0.02% | 608 |
|
|
2022
Q4 | $502K | Sell |
1,231
-246
| -17% | -$95.5K | 0.01% | 791 |
|
|
2022
Q3 | $482K | Sell |
1,477
-417
| -22% | -$153K | 0.01% | 770 |
|
|
2022
Q2 | $665K | Sell |
1,894
-2,329
| -55% | -$950K | 0.03% | 553 |
|
|
2022
Q1 | $2.31M | Buy |
4,223
+20
| +0.5% | +$10.5K | 0.08% | 267 |
|
|
2021
Q4 | $2.77M | Sell |
4,203
-129
| -3% | -$81K | 0.08% | 271 |
|
|
2021
Q3 | $2.69M | Sell |
4,332
-1,182
| -21% | -$794K | 0.09% | 265 |
|
|
2021
Q2 | $3.48M | Sell |
5,514
-400
| -7% | -$221K | 0.11% | 207 |
|
|
2021
Q1 | $2.89M | Buy |
5,914
+5,474
| +1,244% | +$2.74M | 0.1% | 222 |
|
|
2020
Q4 | $220K | Sell |
440
-754
| -63% | -$337K | 0.01% | 892 |
|
|
2020
Q3 | $438K | Buy |
1,194
+493
| +70% | +$182K | 0.02% | 584 |
|
|
2020
Q2 | $232K | Buy |
+701
| New | +$203K | 0.02% | 719 |
|
|
2019
Q3 | – | Sell |
-5,788
| Closed | -$1.59M | – | 830 |
|
|
2019
Q2 | $1.59M | Buy |
+5,788
| New | +$1.43M | 0.17% | 123 |
|
|
2017
Q4 | – | Sell |
-1,731
| Closed | -$270K | – | 653 |
|
|
2017
Q3 | $270K | Sell |
1,731
-320
| -16% | -$50.6K | 0.04% | 411 |
|
|
2017
Q2 | $332K | Buy |
2,051
+42
| +2% | +$6.82K | 0.06% | 337 |
|
|
2017
Q1 | $312K | Sell |
2,009
-56
| -3% | -$7.72K | 0.06% | 325 |
|
|
2016
Q4 | $243K | Buy |
+2,065
| New | +$236K | 0.05% | 398 |
|
|
2015
Q1 | – | Sell |
-460
| Closed | -$34 | – | 1227 |
|
|
2014
Q4 | $34 | Buy |
+460
| New | +$32.3K | ﹤0.01% | 2286 |
|
|
2014
Q3 | – | Sell |
-238
| Closed | -$15.9K | – | 1225 |
|
|
2014
Q2 | $15.9K | Buy |
+238
| New | +$15.1K | ﹤0.01% | 1570 |
|
Other funds holding IDXX
VCM
VPM
B. Riley Wealth Advisors's IDXX Position: Q1 2026 in Review
B. Riley Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 314 shares — an estimated $213K sold.
B. Riley Wealth Advisors first reported a position in IDXX in Q2 2014 and held it in 27 quarters. The position peaked at $3.48M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- B. Riley Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- B. Riley Wealth Advisors sold 314 Idexx Laboratories shares in Q1 2026, an estimated $213K.
- B. Riley Wealth Advisors first reported a position in Idexx Laboratories in Q2 2014 and held it in 27 quarters.
- B. Riley Wealth Advisors's Idexx Laboratories position peaked at $3.48M in Q2 2021.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on B. Riley Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.